News

Gilead's HIV Pipeline Gains Traction With Upcoming FDA Decision For HIV-1 Drug
Gilead's HIV drug lenacapavir earns FDA priority review after strong trial results, with the company planning to double U.S.
Business Wire2y
Gilead Presents Real-World and Long-Term Data From HIV Research Programs at HIV Glasgow 2022
Additionally, Gilead will share new findings on long-acting HIV treatment strategies. Data will include a subgroup analysis from the ... Gilead and the Gilead logo are registered trademarks ...
CBS News11mon
Young Latino gay men account for nearly a third of new HIV infections, analysis finds
Between 2012 and 2022, new HIV infections nationwide decreased by 23% largely due to advanced medical treatments. However, a new analysis by KFF Health News and the Associated Press found that ...
News Medical2y
An automated bioinformatics pipeline to monitor HIV data in real-time
Image Credit: CI Photos / Shutterstock.com Challenges associated with real-time data integration, analysis, and interpretation delay public health responses, particularly when HIV is considered.
Yahoo Finance8mon
Gilead’s Twice-Yearly Lenacapavir for HIV Prevention Reduced HIV Infections by 96% and Demonstrated Superiority to Daily Truvada® in Second Pivotal Phase 3 Trial
Lenacapavir reduced HIV infections by 96% compared to ... sex with partners assigned male at birth. At interim analysis, the independent Data Monitoring Committee (DMC) confirmed that the PURPOSE ...
Medscape2y
Real-World Data on ICI in Patients With HIV and Cancer
It was based on an analysis of data from the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International Consortium (CATCH-IT). The team identified 390 patients with HIV and ...